Further mechanistic screening revealed that both interventions (hepatic AGT knockout vs systemic AngII inhibition) showed similar outcomes in terms of cardiac inflammation, myocardial fibrosis, and ventricular hypertrophy. The gene discussed is AGT; the disease is inflammatory response.